EMBED BIOTECH LIMITED

Active London

Manufacture of irradiation, electromedical and electrotherapeutic equipment

0 employees website.com
Manufacture of irradiation, electromedical and electrotherapeutic equipmentResearch and experimental development on biotechnology
E

EMBED BIOTECH LIMITED

Manufacture of irradiation, electromedical and electrotherapeutic equipment

Founded 7 Feb 2024 Active London, United Kingdom 0 employees website.com
Manufacture of irradiation, electromedical and electrotherapeutic equipmentResearch and experimental development on biotechnology
Accounts Submitted 2 Oct 2025 Next due 30 Nov 2026 7 months remaining
Confirmation Submitted 24 Feb 2026 Next due 20 Feb 2027 9 months remaining
Net assets £-10K
Total assets £6K
Total Liabilities £16K
Charges None No charges registered

Contact & Details

Contact

Registered Address

6th Floor One London Wall London EC2Y 5EB United Kingdom

Website

www.example.com

Full company profile for EMBED BIOTECH LIMITED (15472206), an active company based in London, United Kingdom. Incorporated 7 Feb 2024. Manufacture of irradiation, electromedical and electrotherapeutic equipment. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2024–2024)

Cash in Bank

£4.25k

Net Assets

-£9.80k

Total Liabilities

£15.87k

Turnover

N/A

Employees

N/A

Debt Ratio

261%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

9 Allotments 51,665 Shares £1.52m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
15 Aug 20256,750£270k£40
15 Aug 2025270£11k£40
1 Jul 202524,250£970k£40
1 Jul 2025220£0£0
18 Jun 20256,625£265k£40

Officers

Officers

3 active
Status
Cegla, Frederic, DrDirectorBritish,germanEngland457 Feb 2024Active
Hall, Thomas Ainsley Grant, DrDirectorBritishUnited Kingdom297 Feb 2024Active
Whitsitt, LauraDirectorAmericanUnited States6015 Oct 2025Active

Shareholders

Shareholders (16)

Thomas Ainsley Grant Hall
33.0%
41,700
Richard Jan Van Arkel
13.8%
17,500

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Dr Thomas Ainsley Grant Hall

British

Active
Notified 7 Feb 2024
Residence United Kingdom
DOB July 1996
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Feb 2026Confirmation StatementConfirmation statement made on 6 Feb 2026 with updates
20 Oct 2025OfficersAppointment of Laura Whitsitt as director on 15 Oct 2025
2 Oct 2025AccountsAnnual accounts made up to 28 Feb 2025
5 Sept 2025ResolutionResolutions
4 Sept 2025CapitalAllotment of shares (GBP 1.26365) on 15 Aug 2025
24 Feb 2026 Confirmation Statement

Confirmation statement made on 6 Feb 2026 with updates

20 Oct 2025 Officers

Appointment of Laura Whitsitt as director on 15 Oct 2025

2 Oct 2025 Accounts

Annual accounts made up to 28 Feb 2025

5 Sept 2025 Resolution

Resolutions

4 Sept 2025 Capital

Allotment of shares (GBP 1.26365) on 15 Aug 2025

Recent Activity

Latest Activity

Confirmation statement made on 6 Feb 2026 with updates

2 months ago on 24 Feb 2026

Appointment of Laura Whitsitt as director on 15 Oct 2025

6 months ago on 20 Oct 2025

Annual accounts made up to 28 Feb 2025

6 months ago on 2 Oct 2025

Resolutions

7 months ago on 5 Sept 2025

Allotment of shares (GBP 1.26365) on 15 Aug 2025

7 months ago on 4 Sept 2025